Dotarem and Feeling cold - a phase IV clinical study of FDA data

Summary:

Feeling cold is reported as a side effect among people who take Dotarem (gadoterate meglumine), especially for people who are female, 30-39 old, have been taking the drug for < 1 month also take Omniscan, and have Hormone level abnormal.

The phase IV clinical study analyzes which people have Feeling cold when taking Dotarem. It is created by eHealthMe based on reports of 2,749 people who have side effects when taking Dotarem from the FDA, and is updated regularly.

What is Dotarem?

Dotarem has active ingredients of gadoterate meglumine. eHealthMe is studying from 2,749 Dotarem users. Check the latest studies of Dotarem.

What is Feeling cold?

Feeling cold is found to be associated with 1,337 drugs and 1,618 conditions by eHealthMe. Check the latest studies of Feeling cold.

On Jul, 12, 2026

2,749 people reported to have side effects when taking Dotarem.
Among them, 26 people (0.95%) have Feeling cold.

Among these 26 people:

How long have people been on Dotarem when they have Feeling cold? *

What is the gender of people who have Feeling cold when taking Dotarem? *

female: 64 %
male: 36 %

What is the age of people who have Feeling cold when taking Dotarem? *

What are other drugs people take besides Dotarem? *

What are other side effects people have besides Feeling cold? *

Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 12 people, 46.15%
Hypoaesthesia (reduced sense of touch or sensation): 11 people, 42.31%
Tremor (trembling or shaking movements in one or more parts of your body): 11 people, 42.31%
Nausea (feeling of having an urge to vomit): 10 people, 38.46%
Headache (pain in head): 9 people, 34.62%
Rashes (redness): 8 people, 30.77%
Nausea And Vomiting: 8 people, 30.77%
Dizziness: 8 people, 30.77%
High Blood Pressure: 7 people, 26.92%
Dyspnea (difficult or laboured breathing): 7 people, 26.92%

What are the existing conditions these people have? *

Hypothermia (body temperature drops below the required temperature for normal metabolism and body functions): 2 people, 7.69%
Hypoaesthesia (reduced sense of touch or sensation): 2 people, 7.69%
Hormone Level Abnormal: 2 people, 7.69%
Raynaud's Phenomenon (discoloration of the fingers, toes, and occasionally other areas): 1 person, 3.85%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 1 person, 3.85%
Pain: 1 person, 3.85%
Nuclear Magnetic Resonance Imaging Brain: 1 person, 3.85%
Nuclear Magnetic Resonance Imaging Abdominal: 1 person, 3.85%
High Blood Pressure: 1 person, 3.85%
Dysmenorrhea (painful menstruation): 1 person, 3.85%

* Approximation only. Some reports may have incomplete information.

Do you take Dotarem and have Feeling cold?

- Check whether Feeling cold is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Dotarem:

Dotarem (2,749 reports)

Feeling cold treatments and more:

Feeling cold (33,886 reports)

Browse all side effects of Dotarem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Feeling cold:

Feeling cold (1,337 drugs)

Browse all the conditions that are associated with Feeling cold:

Feeling cold (1,618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gadoterate meglumine (the active ingredients of Dotarem) and Dotarem (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.